Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Nephrology
Study Phase : Discovery
Sponsor : Hoxton Ventures
Deal Size : $8.6 million
Deal Type : Financing
Details : The net proceeds of the financing round will be used to to discover precision medicines for metabolic syndrome-related conditions and to demonstrate proof-of-concept for MultiOmic’s MOHSAIC® platform in diabetic kidney disease.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
May 03, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Nephrology
Highest Development Status : Discovery
Sponsor : Hoxton Ventures
Deal Size : $8.6 million
Deal Type : Financing
LOOKING FOR A SUPPLIER?